摘要
FibroScan的临床应用价值已在慢性丙型肝炎患者中得到广泛验证。近年来,FibroScan也用于慢性乙型肝炎患者肝纤维化的评价。但应注意的是,除操作者的因素外,患者生化指标改变、病毒学因素、代谢状态都有可能影响FibroScan检测值,因此,应进一步界定不同情况下FibroScan的诊断界值。本文对FibroScan在慢性乙型肝炎患者肝纤维化诊断中的应用进行综述。
The clinical application of FibroScan has been widely validated in the patients with chronic hepatitis C. In recent years, it has been used to evaluate liver fibrosis in the patients with chronic hepatitis B. However, it should be considered that changes of biochemical markers, virological factors and metabolic status of the patients as well as personal factor of operators may influence liver stiffness measurement using FibroScan. Therefore, it is necessary to determine the cut-off value of FibroScan in different conditions. This paper focuses on the diagnosis of liver fibrosis by FibroScan in the patients with chronic hepatitis B. [Key words]
出处
《传染病信息》
2010年第3期133-135,共3页
Infectious Disease Information
基金
北京市科委科研课题(Z09050700940902)
国家"十一五"科技重大专项(2008ZX10002-004)
关键词
弹性成像技术
诊断显像
肝纤维化
肝炎
乙型
慢性
elasticity imaging techniques
diagnostic imaging
liver fibrosis
hepatitis B, chronic
